Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy

American Journal of Pathology

Volumn 176, Issue 5, 2010, Pages 2550-2558

  Kern, Timothy S ^a,b   Du, Yunpeng ^a   Miller, Casey M ^a,e   Hatala, Denise A ^a   Levin, Leonard A ^c,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREPROENDOTHELIN; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIABETOGENESIS; DISEASE DURATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOSTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CAPILLARY; TRANSGENIC MOUSE; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 77952028243     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091062     Document Type: Article

References (91)

1. Mohr S, Tang J, Kern TS: Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002, 51:1172-1179 (Pubitemid 34438365)
2. Ning X, Baoyu Q, Yuzhen L, Shuli S, Reed E, Li QQ: Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. Int J Mol Med 2004, 13:87-92
3. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N: Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 2004, 53:2412-2419 (Pubitemid 39145597)
4. Kowluru RA, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radicals Biol Med 1996, 22:587-592
5. Kowluru RA, Tang J, Kern TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001, 50:1938-1942
6. Nishikawa T, Edelstein D, Brownlee M: The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 2000, 77:S26-S30
7. Du Y, Miller CM, Kern TS: Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003, 35:1491-1499 (Pubitemid 37452474)
8. Kanwar M, Chan PS, Kern TS, Kowluru RA: Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007, 48:3805-3811 (Pubitemid 351261121)
9. Guidarelli A, Cerioni L, Tommasini I, Fiorani M, Brune B, Cantoni O: Role of Bcl-2 in the arachidonate-mediated survival signaling preventing mitochondrial permeability transition-dependent U937 cell necrosis induced by peroxynitrite. Free Radic Biol Med 2005, 39:1638-1649 (Pubitemid 41642595)
10. Barbu A, Welsh N, Saldeen J: Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Deltapsi(m)) in pancreatic RINm5F cells: prevention by Bcl-2. Mol Cell Endocrinol 2002, 190:75-82 (Pubitemid 34462053)
11. Saldeen J: Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 2000, 141:2003-2010
12. Fukuda K, Yamamoto M: Acquisition of resistance to apoptosis and necrosis by Bcl-xL over-expression in rat hepatoma McA-RH8994 cells. J Gastroenterol Hepatol 1999, 14:682-690 (Pubitemid 29350122)
13. Yamabe K, Shimizu S, Kamiike W, Waguri S, Eguchi Y, Hasegawa J, Okuno S, Yoshioka Y, Ito T, Sawa Y, Uchiyama Y, Tsujimoto Y, Matsuda H: Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem Biophys Res Commun 1998, 243: 217-223
14. Tsujimoto Y, Shimizu S, Eguchi Y, Kamiike W, Matsuda H: Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways. Leukemia 1997, 11 Suppl 3:380-382 (Pubitemid 27313541)
15. Michaelidis TM, Sendtner M, Cooper JD, Airaksinen MS, Holtmann B, Meyer M, Thoenen H: Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 1996, 17:75-89 (Pubitemid 26251593)
16. Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O: bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci U S A 1995, 92: 4397-4401
17. Dubois-Dauphin M, Frankowski H, Tsujimoto Y, Huarte J, Martinou JC: Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci U S A 1994, 91:3309-3313 (Pubitemid 24130226)
18. Bonfanti L, Strettoi E, Chierzi S, Cenni MC, Liu XH, Martinou JC, Maffei L, Rabacchi SA: Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J Neurosci 1996, 16:4186-4194 (Pubitemid 26192414)
19. Chen J, Flannery JG, LaVail MM, Steinberg RH, Xu J, Simon MI: bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci U S A 1996, 93:7042-7047 (Pubitemid 26243498)
20. Reed JC: Bcl-2 family proteins. Oncogene 1998, 17:3225-3236
21. Harats D, Kurihara H, Belloni H, Ziober A, Ackley D, Cain G, Kurihara Y, Lawn R, Sigal E: Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest 1995, 95:1335-1344
22. Leung JW, Ho MC, Lo AC, Chung SS, Chung SK: Endothelial cell-specific over-expression of endothelin- 1 leads to more severe cerebral damage following transient middle cerebral artery occlusion. J Cardiovasc Pharmacol 2004, 44 Suppl 1:S293-S300
23. Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, Schiffrin EL: Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004, 110:2233-2240 (Pubitemid 39372507)
24. Liu L, Sanz S, Heggestad AD, Antharam V, Notterpek L, Fletcher BS: Endothelial targeting of the Sleeping Beauty transposon within lung. Mol Ther 2004, 10:97-105 (Pubitemid 38885655)
25. Afek A, Zurgil N, Bar-Dayan Y, Polak-Charcon S, Goldberg I, Deutsch M, Kopolovich J, Keren G, Harats D, George J: Overexpression of 15-lipoxygenase in the vascular endothelium is associated with increased thymic apoptosis in LDL receptor-deficient mice. Pathobiology 2004, 71:261-266 (Pubitemid 39370361)
26. Shindo T, Kurihara H, Maemura K, Kurihara Y, Kuwaki T, Izumida T, Minamino N, Ju KH, Morita H, Oh-hashi Y, Kumada M, Kangawa K, Nagai R, Yazaki Y: Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000, 101:2309-2316
27. Zaidi SH, Hui CC, Cheah AY, You XM, Husain M, Rabinovitch M: Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis. J Clin Invest 1999, 103:1211-1219 (Pubitemid 29207255)
28. Ripodas A, de Juan JA, Roldan-Pallares M, Bernal R, Moya J, Chao M, Lopez A, Fernandez-Cruz A, Fernandez-Durango R: Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res 2001, 912:137-143
29. Kern TS, Engerman RL: A mouse model of diabetic retinopathy. Arch Ophthalmol 1996, 114:986-990
30. Kowluru RA, Engerman RL, Kern TS: Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic Res 2000, 32:67-74
31. Kern TS, Engerman RL: Pharmacologic inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 2001, 50:1636-1642 (Pubitemid 33639605)
32. Tang J, Mohr S, Du Y, Kern TS: Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res 2003, 27:7-13 (Pubitemid 36936342)
33. Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 1998, 47:464-469
34. Badr GA, Tang J, Ismail-Beigi F, Kern TS: Diabetes down-regulates Glut1 expression in retina and its microvessels, but not in cerebral cortex or its microvessels. Diabetes 2000, 49:1016-1021 (Pubitemid 30349425)
35. Zheng L, Szabo C, Kern TS: Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004, 53:2960-2967 (Pubitemid 39425922)
36. Kern TS, Engerman RL: Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr Eye Res 1994, 13:863-867
37. Kern TS, Engerman RE: Animal model of human disease: a mouse model of diabetic retinopathy. Comp Pathol Bull 1997, 39:3-6
38. Kowluru RA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 2000, 21:814-819
39. Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, Berkowitz BA, Kern TS: Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 2007, 50:1987-1996 (Pubitemid 47222853)
40. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004, 18:1450-1452 (Pubitemid 39561611)
41. Latti S, Leskinen M, Shiota N, Wang Y, Kovanen PT, Lindstedt KA: Mast cell-mediated apoptosis of endothelial cells in vitro: a paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression. J Cell Physiol 2003, 195:130-138
42. Sima AA, Zhang WX, Cherian PV, Chakrabarti S: Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia 1992, 35:602-607
43. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998, 102: 783-791 (Pubitemid 28399611)
44. Aizu Y, Oyanagi K, Hu J, Nakagawa H: Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin- diabetic rats. Neuropathology 2002, 22:161-170 (Pubitemid 35252706)
45. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M: A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003, 52:506-511 (Pubitemid 36173210)
46. Kusner LL, Sarthy VP, Mohr S: Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci 2004, 45:1553-1561
47. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB: Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 2004, 45:3330-3336 (Pubitemid 39121873)
48. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF: Vascular Damage in a Mouse Model of Diabetic Retinopathy: relation to Neuronal and Glial Changes. Invest Ophthalmol Vis Sci 2005, 46:4281-4287 (Pubitemid 44264633)
49. Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S, Saya H: Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene 1998, 16:933-943 (Pubitemid 28102597)
50. Raghupathi R, Fernandez SC, Murai H, Trusko SP, Scott RW, Nishioka WK, McIntosh TK: BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice. J Cereb Blood Flow Metab 1998, 18:1259-1269 (Pubitemid 28509841)
51. Nakamura M, Raghupathi R, Merry DE, Scherbel U, Saatman KE, McIntosh TK: Overexpression of Bcl-2 is neuroprotective after experimental brain injury in transgenic mice. J Comp Neurol 1999, 412: 681-692 (Pubitemid 29409679)
52. Quiambao AB, Tan E, Chang S, Komori N, Naash MI, Peachey NS, Matsumoto H, Ucker DS, Al-Ubaidi MR: Transgenic Bcl-2 expressed in photoreceptor cells confers both death-sparing and death-inducing effects. Exp Eye Res 2001, 73:711-721 (Pubitemid 34014399)
53. Cenni MC, Bonfanti L, Martinou JC, Ratto GM, Strettoi E, Maffei L: Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice. Eur J Neurosci 1996, 8:1735-1745 (Pubitemid 26289691)
54. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE: Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993, 262:1274-1277 (Pubitemid 24036095)
55. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251
56. Distelhorst CW, Lam M, McCormick TS: Bcl-2 inhibits hydrogen peroxide-induced ER Ca2+ pool depletion. Oncogene 1996, 12:2051-2055 (Pubitemid 126424666)
57. Bruce-Keller AJ, Begley JG, Fu W, Butterfield DA, Bredesen DE, Hutchins JB, Hensley K, Mattson MP: Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J Neurochem 1998, 70:31-39 (Pubitemid 28020825)
58. Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW: Identification of the bcl-2 family of genes in the rat retina. Invest Ophthalmol Vis Sci 1997, 38:2545-2553
59. Chen ST, Garey LJ, Jen LS: Bcl-2 proto-oncogene protein immunoreactivity in normally developing and axotomised rat retinas. Neurosci Lett 1994, 172:11-14
60. Chen ST, Gentleman SM, Garey LJ, Jen LS: Distribution of beta-amyloid precursor and B-cell lymphoma protooncogene proteins in the rat retina after optic nerve transection or vascular lesion. J Neuropathol Exp Neurol 1996, 55:1073-1082
61. Chen ST, Wang JP, Garey LJ, Jen LS: Expression of beta-amyloid precursor and Bcl-2 proto-oncogene proteins in rat retinas after intravitreal injection of aminoadipic acid. Neurochem Int 1999, 35: 371-382
62. Chuang JI, Chen ST, Chang YH, Jen LS: Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment. J Chem Neuroanat 2001, 21:215-223
63. Grosche J, Hartig W, Reichenbach A: Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl-2 protooncogene protein by Muller (glial) cells in retinal light damage of rats. Neurosci Lett 1995, 185:119-122
64. Voehringer DW, Meyn RE: Redox aspects of Bcl-2 function. Antioxid Redox Signal 2000, 2:537-550
65. Deveraux QL, Schendel SL, Reed JC: Antiapoptotic proteins. The bcl-2 and inhibitor of apoptosis protein families. Cardiol Clin 2001, 19:57-74
66. Kuwana T, Newmeyer DD: Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 2003, 15:691-699
67. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J: Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994, 13:1017-1030
68. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, Ferran C: Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest 1999, 103: 543-553
69. Ellerby LM, Ellerby HM, Park SM, Holleran AL, Murphy AN, Fiskum G, Kane DJ, Testa MP, Kayalar C, Bredesen DE: Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J Neurochem 1996, 67:1259-1267
70. Lee M, Hyun DH, Marshall KA, Ellerby LM, Bredesen DE, Jenner P, Halliwell B: Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free Radic Biol Med 2001, 31:1550-1559 (Pubitemid 34024977)
71. Hoetelmans RW, Vahrmeijer AL, van Vlierberghe RL, Keijzer R, van de Velde CJ, Mulder GJ, Van Dierendonck JH: The role of various Bcl-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain. Cell Prolif 2003, 36:35-44
72. Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM: Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 1995, 10:2297-2305
73. Iida N, Sugiyama A, Myoubudani H, Inoue K, Sugamata M, Ihara T, Ueno Y, Tashiro F: Suppression of arachidonic acid cascade-mediated apoptosis in aflatoxin B1-induced rat hepatoma cells by glucocorticoids. Carcinogenesis 1998, 19:1191-1202
74. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348:334-336
75. Reed JC, Talwar HS, Cuddy M, Baffy G, Williamson J, Rapp UR, Fisher GJ: Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts. Exp Cell Res 1991, 195:277-283
76. Boulakia CA, Chen G, Ng FW, Teodoro JG, Branton PE, Nicholson DW, Poirier GG, Shore GC: Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly-(ADP-ribose) polymerase. Oncogene 1996, 12:529-535
77. Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M: Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol 1998, 152: 1453-1462
78. Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K: Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004, 45:2760-2766
79. Novack DV, Korsmeyer SJ: Bcl-2 protein expression during murine development. Am J Pathol 1994, 145:61-73
80. Merry DE, Korsmeyer SJ: Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997, 20:245-267
81. Chen ST, Hsu JR, Hsu PC, Chuang JI: The retina as a novel in vivo model for studying the role of molecules of the Bcl-2 family in relation to MPTP neurotoxicity. Neurochem Res 2003, 28:805-814
82. Giardino I, Edelstein D, Brownlee M: Bcl-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 1996, 97:1422-1428
83. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W: Effect of aminoguanidine on the generation of superoxide anion and nitric oxide by peripheral blood granulocytes of rats with streptozotocin-induced diabetes. Clin Chim Acta 1998, 278:45-53
84. Kashima K, Sato N, Sato K, Shimizu H, Mori M: Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats. Endocrinology 1998, 139:3404-3408 (Pubitemid 28512295)
85. Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A, Van Dyke TE: Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol 2006, 177:7250-7256 (Pubitemid 44715094)
86. Ding Y, Kantarci A, Hasturk H, Trackman PC, Malabanan A, Van Dyke TE: Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. J Leukoc Biol 2007, 81: 520-527 (Pubitemid 46198404)
87. Gubitosi-Klug RA, Talahalli R, Du Y, Nadler JL, Kern TS: 5-Lipoxygenase, but not 12/15-Lipoxygenase. Contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 2008, 57:1387-1393
88. Oshitari T, Roy S: Diabetes: a potential enhancer of retinal injury in rat retinas. Neurosci Lett 2005, 390:25-30 (Pubitemid 41317784)
89. Kowluru RA, Abbas SN: Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci 2003, 44:5327-5334
90. Podesta F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M: Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 2000, 156:1025-1032 (Pubitemid 30626960)
91. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK: The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes. Invest Ophthalmol Vis Sci 2005, 46:2210-2218